Advance against royalties

Nicox to Receive $2 Million from Ocumension Therapeutics as Advance Milestone Payment under ZERVIATE® Agreement

Retrieved on: 
Monday, July 5, 2021
Intellectual property law, NicOx, Royalty payment, Advance against royalties, Cetirizine, Chemistry, Health care, Functional groups

Under the amended agreement, Ocumension will immediately pay Nicox $2 million in full advance payment of the future development and regulatory milestones for the product.

Key Points: 
  • Under the amended agreement, Ocumension will immediately pay Nicox $2 million in full advance payment of the future development and regulatory milestones for the product.
  • Nicox remains eligible to receive the same sales milestones of up to US$17.2 million together with tiered royalties of between 5% and 9% of net sales of ZERVIATE by Ocumension.
  • ZERVIATE was developed by Nicox as the first and only formulation of cetirizine for topical application in the eye.
  • Nicox disavows any obligation to correct or to update the information contained in analyst reports.

REPEAT - Gold Lion Options the South Orogrande, Robber Gulch, and Erikson Ridge Gold Projects in Idaho from EMX Royalty

Retrieved on: 
Tuesday, April 7, 2020
Physical sciences, Chemistry, Precious metals, Intellectual property law, Atoms, Expense, Patent law, Royalty payment, Advance against royalties, Gold, Bullion

Gold Lion may, at its election, make up to one-half of the payment for the first 0.5% through the issuance of Gold Lion common shares.

Key Points: 
  • Gold Lion may, at its election, make up to one-half of the payment for the first 0.5% through the issuance of Gold Lion common shares.
  • AAR payments will constitute prepayment of and advance against the 3.5% NSR royalty and will be set off against 70% of the 3.5% NSR royalty.
  • Gold Lion may elect to make any such milestone payments in cash or in kind as refined bullion.
  • 1Adjacent Properties - This news release contains information about adjacent properties on which Gold Lion does not have the right to explore or mine.

Gold Lion Options the South Orogrande, Robber Gulch, and Erikson Ridge Gold Projects in Idaho from EMX Royalty

Retrieved on: 
Tuesday, April 7, 2020
Physical sciences, Chemistry, Precious metals, Intellectual property law, Atoms, Expense, Patent law, Royalty payment, Advance against royalties, Gold, Bullion

Gold Lion may, at its election, make up to one-half of the payment for the first 0.5% through the issuance of Gold Lion common shares.

Key Points: 
  • Gold Lion may, at its election, make up to one-half of the payment for the first 0.5% through the issuance of Gold Lion common shares.
  • AAR payments will constitute prepayment of and advance against the 3.5% NSR royalty and will be set off against 70% of the 3.5% NSR royalty.
  • Gold Lion may elect to make any such milestone payments in cash or in kind as refined bullion.
  • 1Adjacent Properties - This news release contains information about adjacent properties on which Gold Lion does not have the right to explore or mine.

Qrons Granted Exclusive World-Wide License by Dartmouth College for Intellectual Property Related to 3D Printable Materials in Human and Animal Health

Retrieved on: 
Monday, October 14, 2019
Intellectual property law, Intangible assets, Articles, Patent law, Human behavior, Contents, 3D printing, Royalty payment, License, Advance against royalties, Intellectual property, Patent

The Agreement provides for the payment by Qrons of initial and annual license fees and royalty payments based upon Qrons' product sales.

Key Points: 
  • The Agreement provides for the payment by Qrons of initial and annual license fees and royalty payments based upon Qrons' product sales.
  • Qrons is using the 3D process covered by the patent entitled Mechanically Interlocked Molecules-based Materials for 3D Printing as part of its injury specific 3D printable implants to treat penetrating brain injuries.
  • Qrons is also a party to a Sponsored Research Agreement with Dartmouth to advance the license or ownership of additional Intellectual Property.
  • Jonah Meer, Qrons Co-founder and CEO, added, Were excited to have concluded negotiations to acquire an exclusive license for this important intellectual property.